Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/5/2022 | $12.00 → $7.00 | Buy → Neutral | ROTH Capital |
| 8/19/2021 | Buy → Neutral | H.C. Wainwright |
15-12G - SHARPS COMPLIANCE CORP (0000898770) (Filer)
EFFECT - SHARPS COMPLIANCE CORP (0000898770) (Filer)
EFFECT - SHARPS COMPLIANCE CORP (0000898770) (Filer)
ROTH Capital downgraded Sharps Compliance from Buy to Neutral and set a new price target of $7.00 from $12.00 previously
H.C. Wainwright downgraded Sharps Compliance from Buy to Neutral
HC Wainwright & Co. reiterated coverage of Sharps Compliance with a rating of Buy and set a new price target of $25.00 from $18.00 previously
SC 13D - SHARPS COMPLIANCE CORP (0000898770) (Subject)
SC 13G - SHARPS COMPLIANCE CORP (0000898770) (Subject)
SC 13G - SHARPS COMPLIANCE CORP (0000898770) (Subject)
3 - SHARPS COMPLIANCE CORP (0000898770) (Issuer)
4 - SHARPS COMPLIANCE CORP (0000898770) (Issuer)
4 - SHARPS COMPLIANCE CORP (0000898770) (Issuer)
HOUSTON, April 04, 2022 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ:SMED) ("Sharps" or the "Company"), a leading full-service national provider of comprehensive waste management solutions including medical, pharmaceutical and hazardous, today announced that it has appointed W. Patrick Mulloy ("Pat") as President & Chief Executive Officer. Mr. Mulloy succeeds David P. Tusa, who resigned from the role effective April 1, 2022, to pursue other endeavors. Pat Mulloy has served as a director of the Company since February 2021. Mr. Mulloy has more than 20 years of experience in the senior housing and long-term care industry, having led three successful senior housing companies. Most re
HOUSTON, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ:SMED) ("Sharps" or the "Company"), a leading full-service national provider of comprehensive waste management solutions including medical, pharmaceutical and hazardous, today announced that it has expanded its leadership team with the appointment of Eric Bauer as Executive Vice President & Chief Financial Officer. In his new role, Mr. Bauer will oversee all aspects of Sharps' finance and accounting organization and play a key role in developing and implementing the Company's strategic initiatives and mergers and acquisitions efforts. Diana P. Diaz continues with the Company as Vice President and Chief Accounting Off
HOUSTON, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ:SMED) ("Sharps" or the "Company"), a leading full-service national provider of comprehensive waste management solutions including medical, pharmaceutical and hazardous, today announced the appointment of Gary R. Enzor to its Board of Directors. Mr. Enzor brings extensive experience with Fortune 50 companies across a broad range of industries, including transportation, aerospace, automotive, chemical and technology. He currently serves as director of Boasso Global, which operates the largest bulk liquid chemical intermodal transportation and depot network in the United States and Europe, and serves on the Board of D
Gainers Sharps Compliance Corp. (NASDAQ:SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share. Canoo Inc. (NASDAQ:GOEV) shares climbed 53.2% to close at $3.63 after Walmart signed a definitive agreement with the company to purchase 4,500 all-electric delivery vehicles, beginning with the Lifestyle Delivery Vehicle, with the option to purchase up to 10,000 units. Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) jumped 42.2% to close at $6.67 after the company announced positive interim results from a Phase 2 clinical trial evaluating setmelanotide for the treatment of severe obesity and hyper
Gainers Sharps Compliance (NASDAQ:SMED) stock increased by 193.5% to $8.37 during Tuesday's regular session. Sharps Compliance's stock is trading at a volume of 3.0 million shares as of 13:30 EST. This is 1500.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $162.5 million. Rhythm Pharmaceuticals (NASDAQ:RYTM) shares increased by 22.81% to $5.76. The current volume of 1.2 million shares is 142.0% of Rhythm Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $290.2 million. Alpha Teknova (NASDAQ:TKNO) shares increased by 20.78% to $9.18. The market v
Third quarter revenue of $17.6 million decreased 36% compared to the prior year; Excluding COVID-19 related immunization activity, third quarter revenue increased 24%Route-based customer locations increased 21% to 18,600 from 15,400 in the prior year; billings increased 12%Professional market billings grew 19% compared to prior year third quarterHome Healthcare billings increased 21% compared to third quarter 2021 Third quarter immunization-related mailback billings of $2.9 million decreased as compared to $20.2 million in third quarter 2021; Increased substantially over pre-COVID levels of $0.7 million in third quarter 2020 MedSafe billings increased 19% to $1.5 million from $1.2 million in
HOUSTON, April 26, 2022 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ:SMED) announced today that it has rescheduled the release of its third quarter 2022 financial results. The Company will release third quarter 2022 results for the period ended March 31, 2022, before the opening of the financial markets on Thursday, May 12, 2022. A conference call and webcast will follow at 11:00 a.m. ET, in which management will discuss the Company's financial results, key market initiatives and business strategy. The Sharps Compliance conference call can be accessed by domestic callers by dialing (877) 545-0320. International callers may access the call by dialing (973) 528-0002. Callers should
HOUSTON, April 19, 2022 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ:SMED) announced today that it will release its third quarter 2022 results for the period ended March 31, 2022, before the opening of the financial markets on Wednesday, April 27, 2022. A conference call and webcast will follow at 11:00 a.m. ET, in which management will discuss the Company's financial results, key market initiatives and business strategy. The Sharps Compliance conference call can be accessed by domestic callers by dialing (877) 545-0320. International callers may access the call by dialing (973) 528-0002. Callers should use conference entry code 797852. The webcast can be monitored at www.sharpsinc
LOS ANGELES, Aug. 22, 2022 /PRNewswire/ -- Aurora Capital Partners ("Aurora"), a leading middle-market private equity firm, today announced the successful completion of the previously commenced all-cash tender offer by Aurora's affiliate, Raven Houston Merger Sub, Inc. ("Purchaser") to purchase all of the issued and outstanding shares of common stock (the "Shares") of Sharps Compliance Corp. (NASDAQ:SMED) ("Sharps"), a leading full-service national provider of comprehensive waste management solutions including medical, pharmaceutical and hazardous waste, for $8.75 per share, net to the seller in cash, without interest and less any applicable withholding taxes. The tender offer expired one mi
HOUSTON, July 25, 2022 /PRNewswire/ -- Aurora Capital Partners ("Aurora"), a leading middle-market private equity firm, today announced that its affiliate, Raven Buyer, Inc. ("Parent"), has directed its wholly-owned subsidiary, Raven Houston Merger Sub, Inc. ("Purchaser") to commence its previously announced all-cash tender offer to acquire all of the issued and outstanding shares of common stock of Sharps Compliance Corp. (NASDAQ:SMED) ("Sharps"), a leading full-service national provider of comprehensive waste management solutions including medical, pharmaceutical and hazardous waste, for $8.75 per share, net to the seller in cash, without interest and less any applicable withholding taxes
HOUSTON, July 12, 2022 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ:SMED) ("Sharps" or the "Company"), a leading full-service national provider of comprehensive waste management solutions including medical, pharmaceutical and hazardous waste, today announced that it has entered into a definitive merger agreement to be acquired by an affiliate of Aurora Capital Partners ("Aurora"), a leading middle-market private equity firm. Under the terms of the merger agreement, Aurora will commence an all-cash tender offer to acquire all of the issued and outstanding shares of Sharps for $8.75 per share, which represents a premium of approximately 207% over Sharps' closing share price on July 1